4//SEC Filing
Sobel Alan D. 4
Accession 0001104659-22-023820
CIK 0001175151other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:31 PM ET
Size
6.4 KB
Accession
0001104659-22-023820
Insider Transaction Report
Form 4
Sobel Alan D.
Director
Transactions
- Gift
Common Stock
2022-02-14+2,000→ 2,000 total(indirect: By Trust)
Holdings
- 69,300
Common Stock
Footnotes (2)
- [F1]These shares are held in the Bernard Sobel Revocable Trust (the "Trust'"). On February 14, 2022, the reporting person became a trustee of the Trust. The reporting person is also a named beneficiary of the Trust. Accordingly, the reporting person may be deemed the beneficial owner of the shares held in the Trust.
- [F2]Includes the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001639386
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:31 PM ET
- Size
- 6.4 KB